摘要
目的观察红花黄色素注射液在脑梗死急性期的治疗作用及安全性。方法将符合急性脑梗死诊断标准的104例患者,随机分为红花黄色素治疗组和对照组。两组均给予抗血小板聚集及一般营养脑神经细胞药物常规治疗。观察两组治疗前、治疗后第14天的神经功能缺损程度,并进行卒中量表(NIHSS)评分。结果红花黄色素治疗组治疗后神经功能恢复、NIHSS评分均明显优于对照组(P<0.05)。结论红花黄色素治疗急性脑梗塞安全有效。
OBJECTIVE To observe the clinical curative effect and safe of safflow yellow（ SY） in treating acute cerebral infarction. METHODS The 104 patients on acute cerebral infarction were divided into control group and SY therapeutic group. Both group were given cerebral nerve nutriceutical and antiplatelet routine treatment. The degree of neurologic impairment of the two groups was observed and evaluated by NIHSS before treatment and after treatment for 14 days.RESULTS The nerve functional recovery of the SY therapeutic group obviously surpassed that of the control group.There was statistical significance of total effective rate and the NIHSS score between the two group（P〈0.05） .CONCLUSION Safflow yellow can improve neurological function in acute cerebral infarction.
出处
《海峡药学》
2009年第11期115-116,共2页
Strait Pharmaceutical Journal
关键词
红花黄色素
急性脑梗死
Safflow yellow
Acute cerebral infarction
